Search
for

    Learn

    0 / 0 results
    — no results

    Research

    5 / 29 results

      research Misoprostol Therapeutics Revisited

      64 citations, January 2001 in “Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy”
      Misoprostol has many medical benefits, including protecting against injuries, aiding in disease treatment, and improving drug effects.
      Factors to Consider When Selecting Antiulcer Drugs for a Formulary

      research Factors to Consider When Selecting Antiulcer Drugs for a Formulary

      August 1994 in “Drugs & Therapy Perspectives”
      The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.
      Alopecia: The Search for Novel Agents Continues

      research Alopecia: The Search for Novel Agents Continues

      11 citations, August 1997 in “Expert Opinion on Therapeutic Patents”
      Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.
      Evaluation of Serum Ferritin, Creatinine and Liver Enzymes in Patients with ß- thalassemia After Administration of Deferasirox

      research Evaluation of Serum Ferritin, Creatinine and Liver Enzymes in Patients with ß- thalassemia After Administration of Deferasirox

      April 2023 in “Tikrit Journal of Pharmaceutical Sciences”
      The study on 85 patients with ß-thalassemia in Kirkuk, Iraq, found that deferasirox, an oral iron chelator, effectively reduced serum ferritin levels in 55.3% of patients, indicating a decrease in iron overload. Some adverse effects were observed, including elevated serum creatinine in 25.8% of patients, elevated liver enzymes, and hair loss in 2 patients. Despite these side effects, deferasirox was generally well-tolerated, and its adverse effects could be managed by adjusting the dosage. The study concludes that deferasirox is a suitable treatment for managing iron overload in ß-thalassemia patients.

    Community Join

    0 / 0 results
    — no results